Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.The US FDA has approved Teva Women's Health's sale of Plan B One-Step (levonorgestrel) tablet 1.5mg as an over-the-counter contraceptive to consumers 15years old and more in the US.
Subscribe to our email newsletter
Plan B One-Step will become the first contraceptive to be available in the Family Planning Aisle in Stores across the country.
Teva Women’s Health US Brand Pharmaceuticals vice president and general manager Marty Berndt said, "Today, we welcome the FDA’s decision to provide extended and improved access to this important product, a significant milestone for women."
Strict age verification procedures will be followed at the retail for the sale of Plan B One-Step, which is not an abortifacient and do not harm existing pregnancy.
The progestin-only emergency contraceptive is developed to prevent pregnancy when administered 72 hours following birth control failure or unprotected sex, according to the company.